Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Yttriga, yttrium [90Y] chloride, Date of authorisation: 19/01/2006, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Yuvanci, macitentan,tadalafil, Date of authorisation: 27/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation: 30/06/2014, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Date of authorisation: 19/06/2025, Revision: 3, Status: Authorised

Summary of opinion: BTVPUR, 21/05/2026 Positive

Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 2, Status: Authorised

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026

Summary of opinion: Braftovi, 21/05/2026 Positive

Summary of opinion: Iclusig, 21/05/2026 Positive